thiazolidines has been researched along with Proteinuria in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atsumi, Y; Baba, M; Hotta, N; Kawamori, R; Kishikawa, H; Nakamura, J; Oikawa, S; Shigeta, Y; Yamada, N; Yasuda, H | 1 |
| Betsholtz, C; Dunér, F; Hultenby, K; Patrakka, J; Sistani, L; Tryggvason, K; Udumala, S; Uhlen, M; Wernerson, A | 1 |
| Cohen, EP; Fish, BL; Moulder, JE; Raife, TJ; Regner, KR | 1 |
| Horie, M; Mase, T; Nagaoka, H; Sakurai, Y; Tomioka, K; Yamada, T | 1 |
1 trial(s) available for thiazolidines and Proteinuria
| Article | Year |
|---|---|
Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat.
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Long-Term Care; Male; Middle Aged; Patient Selection; Proteinuria; Rhodanine; Thiazolidines; Treatment Outcome | 2008 |
3 other study(ies) available for thiazolidines and Proteinuria
| Article | Year |
|---|---|
Pdlim2 is a novel actin-regulating protein of podocyte foot processes.
Topics: Actin Cytoskeleton; Actinin; Adaptor Proteins, Signal Transducing; Angiopoietin-Like Protein 1; Animals; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion; Extracellular Matrix; Fluorescent Antibody Technique; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; HEK293 Cells; Humans; Immunoprecipitation; LIM Domain Proteins; Membrane Proteins; Mice; Microscopy, Immunoelectron; Nephrosis, Lipoid; Podocytes; Proteinuria; Reverse Transcriptase Polymerase Chain Reaction; Stress Fibers; Thiazolidines; Transcription Factors; Transfection; Two-Hybrid System Techniques | 2011 |
Retinoic acid exacerbates experimental radiation nephropathy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Extracellular Matrix; Fibrosis; Hypertension, Renal; Kidney; Kidney Diseases; Kidney Failure, Chronic; Proteinuria; Pyridones; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Tretinoin; Uremia; Whole-Body Irradiation | 2002 |
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Male; Metabolic Clearance Rate; Methylprednisolone; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Ticlopidine; Triazoles | 1991 |